Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Gus, I look at shares available on iborrowdesk.com each morning. It appears that these shares are used at least in part to keep the ask loaded and therefore try to control the rise. If you look now you will see there are only 75,000 shares available. 425,000 were borrowed this morning so it looks like their ammo is running low. IMO
It does seem there is something in play that has not been anticipated. We have heard nothing about Direct for a long time and we know there is a great need for this type of treatment. I am not in the buyout camp at this point but approval for the platform and we are gonna have BP stalking us.
There is no way that NWBO management (those in a need to know) do not know the outcome of the L trial. You can argue whether the trial has been unblinded or not. Makes no difference to me but they know the outcome of this trial and it's positive! And they have probably known for quite some time. My question is whether it is at all possible that they get some kind of approval for Direct at the same time? Is there a regulatory pathway from a small phase 1/2 for this to happen? This would be the kind of news that would blow the top off this thing.
We estimate that our net proceeds from the offering will be approximately $4,259,790, after deducting estimated expenses payable by us in connection with such closing.
We intend to use the net proceeds from this offering for general corporate purposes, which may include working capital, capital expenditures (including acceleration of the expansion of the facilities for production of DCVax® products in the UK[color=red][/color]), research and development expenditures, regulatory affairs expenditures, clinical trial expenditures, and acquisitions of new technologies and investments. See “USE OF PROCEEDS” on page S-2 of this prospectus supplement.
Going private? With the preferred converted Linda and friendlies are in the the driver's seat. Couldn't say as I blame them given how corrupt the market is.
You didn't account for market potential. You are comparing a pebble to a boulder. Think!
But they pulled the 500k as best I can tell. Either way, they are throwing the road spikes down.
Looks like some "spoofing" going on :)
And 9 million shares short. Sure hate it for 'em :)
Flip, I would say the real need for manufacturing in various strategic locations would be the time differences. Fedex' sort in Memphis wraps up at about 2:00 a.m. or so. They launch east coast flights first generally by 3:00 a.m. Now add 5 hours to lets say U.K. it is already 8:00 a.m. plus flight time. This puts the flight arriving mid afternoon. Run a localized sort and get the pkg out for delivery it's close of business time there in jolly ol' England. I worked for Fedex Express for 17 years, and have watched the sort in the Memphis HUB on numerous occasions. It is open to the public if you want to stay up all night. The HUB sort is an engineering marvel to say the least. Two or so million packages/docs come in and are sorted and back out to their destinations within 3 hours or so. These liquid nitrogen containers NWBO uses to transport the live cells have been around I would say at least 20 years. For irony, the founder of FEDEX, Mr. Fred Smith, faced similar challenges like NWBO has. Things were slow to get started and all his investors had cut him off. He was one payroll away from having to close up shop. Mr. Smith went to Vegas and won payroll. As they say, the rest is history. Oh, and his Yale professor gave him a "C" on his paper in which he theorized the concept of Fedex using the Hub and Spoke sort method. That Yale professor said it would NEVER work. HMMM Sound familiar.
Flip, did u catch the news from Argos today? They have decided to continue their trial. Wonder if you would take a look at today's news and let us know what you think? Appears Linda is doing the right thing by letting the events/data fully mature.
I like the way you think abeta. I was thinking along these lines when I read the 10k yesterday about the self imposed halt outside of the u.s. Germany will embrace the new paradigm first IMO.
There are varying degrees of disease state within GBM diagnosis, but to say someone with GBM isn't very sick is ludicrous.
TC just sent msg via twitter under wife's acct.. Tks
Can I find you on FB under TC Trader?
TC, from today's PR this jumped out at me. "They also will receive three month Class B warrants to purchase up to approximately 21.6 million shares of common stock with an exercise price of $1.00 per share." So this takes us to Mid June timeframe. Clearly NWBO expecting news by this time. Your thoughts?
Maybe there were third parties interested, but when all deals were put on the table, the company holding the debt offered the best deal. Ex. You wanna refinance your house. You look at various lenders, but just so happens your current mortgage company gives you the best rate. You refinance with your current mortgage company right? Nobody knows what they don't know! The recent deals have been very friendly to NWBO. That should be your take away.
Short term (next 1 to 2 years) on "L" approval 10 billion MC minimum. If Direct were also to get approval a few years down the road we would be looking at MC similar to Celgene 50 to 100 billion. I would look for BP to be falling all over themselves to try and buy them under 25 billion. That will be mostly be up to Linda to decide.
Please have a tissue at the ready before reading this. But I must break some bad news here. The New York Post reported today that TheStreet.com and our beloved TV swindle man has had to layoff 12 employees due to struggling finances. Now don't get too upset. I'm sure Mr. Feuerstein will be kept on board because he does such important, important work and we can look forward to more accurate and unbiased reporting on NWBO.
Thanks Flip.
Thanks Flip. Aren't we close to having the last enrollees past 18 months now? So maybe to pass the 18 mos. we would be looking at approx. another 2 months continuance of the trial?
Senti, hypothetical here. Let's say NWBO updates us on the phase 3 next week and says we have reached 238 events, or some number short of the 248 needed. Or not even provide a number just say we haven't reached 248 yet. Would that give LP enough confidence to go ahead and unblind the trial? Would we just keep waiting? Couldn't the FDA step in and say ok eventing is so slow we need to stop and look? Flipper or anyone with trial knowledge feel free to address. TIA
Thanks for the info Homebrew. Makes sense. I guess a MM could also use the intraday short sales to control the price of a stock as well. We know this has happened in the past because some have been fined for doing so. It's a tangled web.
According to FINRA short interest is 3 million shares that's down from 13 million a couple months ago. This coincides with what I have been seeing in the daily short volume. Very little to no shorting in NWBO over the last month or so. Thanks for telling me about the FINRA site. I will definitely start looking there as well.
Not sure how you would know it's all MM activity? I like learning so educate me.
We've been climbing up hill for a long time now. I just think the view is gonna be spectacular when we reach the top. I'm glad to have been on this journey with folks like you, flipper, senti and a few others. I haven't added shares in several months but thinking I may pick up a few more. What the heck right? The tumblers seem to be falling into place.
Major change in the pattern just before xmas.
Thanks TC. You concur with that 4 week timeline?
A couple of weeks before moving to the OTC short volume virtually dried up compared to what it had normally been. Short volume was running on average around 50% of the daily volume. Then it started dropping to 10 to 20% and now it is literally almost non existent. Having watched the daily short volume for the past 3 years this is a major departure from the norm. According to short squeeze .com it looks like shorts covered around 10 million shares during the past month or so. Since we moved to the OTC I can't confirm this covering like you could with Nasdaq.com short interest. So no daily short volume and shorts covering is all good to me. Shorts either know something or they just don't like the risk reward right now and it's more expensive to short on OTC stocks...so I'm told. JMHO
Shortvolume.com is pretty good. Updated daily after 6 pm (east coast). When shortanyalitcs.com was active I would compare the two and they were pretty close in their numbers. "If" short volume.com numbers are correct someone or entity has been accumulating for at least a month. That's why I asked the question about the 13g filing criteria. IMO.....Something is going on behind the scenes.
Can an entity accumulate more than 10% of a company and not have to file a 13g within 3 days? Definitely accumulation or short covering taking place but can't use shortanalytics.com since I mentioned them a couple of weeks ago their website has not been updating each day. I'm not a conspiracy theorist but......guess it was just a coincidence.
Shhhh....Don't tell 'em TC. :)
My wife used to work for Sanofi several years ago so I'm pretty familiar with how they operate. They never seemed to be sure of the direction they wanted to go. The MNKD deal was typical of them. Commit but not commit. Doomed to fail from the beginning. Contrary to many detractors, Linda is very smart and would not fall for the co-promotion pitfall of DCVAX.
Thanks Flipper. Seems that if we go by the "need", BMY and AZN would be strong candidates. Ideally we could stay independent and sell to all of them. I just don't know how long Linda and Les are in this for. I would think they would at some point want to step away and enjoy life a little.
Flipper, you've recently made several references to a potential acquisition of NWBO. I certainly am in agreement that this is a strong possibility but only after successful Phase 3. If you were to speculate, which BP do you think would be the best fit to advance NWBO's pipeline? I think Gilead is probably the most innovative and well run BP but they don't meet the essential CI criteria. I just don't want to see another Mannkind/Sanofi debacle. TIA and as always, thanks for your rational posts to the board.
Looks like things are about to get more interesting.
This has been going on for weeks. Masking the buys.
This has been going on for weeks. Masking the buys.
Just look like sells. They're not. Check shortanalytics.com after 7:20 pm today you will see the trades for today reported by FINRA. Look at the last couple weeks, the picture becomes clearer.
Takeda buying Ariad and Ipsen buying Merrimack this morning. BP on the move for oncology treatments. NWBO upon successful Phase 3 will be the crown jewel that will have many bidders.